Sichuan Kelun Pharmaceutical Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Public

  • Employees
  • 20,127

Employees

  • Stock Symbol
  • 002422

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $6.34
  • (As of Wednesday Closing)

Sichuan Kelun Pharmaceutical General Information

Description

Sichuan Kelun Pharmaceutical Co Ltd is a China-based pharmaceutical company focused on the manufacturing of infusion products, antibiotics, and various medical devices. The company operates its businesses through three segments. The Twinings segment focuses on producing pharmaceutical intermediates. The Botai segment is dedicated to the research, development, manufacturing, and commercialization of medicines. The Other Business segment covers activities such as the development and production of large-volume injections, along with the research, manufacturing, and sales of additional pharmaceutical products and related businesses.

Contact Information

Website
www.kelun.com
Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 36 West Baihua Road
  • Chengdu, Sichuan 610071
  • China
+86 400
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • Number 36 West Baihua Road
  • Chengdu, Sichuan 610071
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sichuan Kelun Pharmaceutical Stock Performance

As of 18-Nov-2026, Sichuan Kelun Pharmaceutical’s stock price is $6.34. Its current market cap is $10.1B with 1.59B shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.34 $6.35 $4.02 - $7.79 $10.1B 1.59B 19.5M $0.18

Sichuan Kelun Pharmaceutical Financials Summary

As of 30-Sep-2026, Sichuan Kelun Pharmaceutical has a trailing 12-month revenue of $2.66B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 9,712,395 6,875,151 6,755,256 6,653,831
Revenue 2,662,087 2,574,342 3,039,863 3,032,409
EBITDA 399,152 531,915 787,001 718,351
Net Income 285,563 236,665 409,157 347,160
Total Assets 6,419,177 5,693,373 5,111,746 5,142,751
Total Debt 560,323 500,864 576,355 1,007,177
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sichuan Kelun Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sichuan Kelun Pharmaceutical‘s full profile, request access.

Request a free trial

Sichuan Kelun Pharmaceutical Patents

Sichuan Kelun Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026103427-A1 Double butterfly valve-based sterile medicine transfer system and sterile medicine transfer method Pending 15-Nov-2024
WO-2026103486-A1 Method for determining contents of linoleic acid and α-linolenic acid in fat emulsion injection Pending 12-Nov-2024
WO-2026086694-A1 Pediatric compound amino acid injection and preparation method therefor Pending 23-Oct-2024
WO-2025020316-A1 Cavity welding mold Inactive 27-Jul-2023
WO-2025020379-A1 Multi-chamber sterilization and water removal device for infusion bags Inactive 27-Jul-2023 A61L2/26
To view Sichuan Kelun Pharmaceutical’s complete patent history, request access »

Sichuan Kelun Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sichuan Kelun Pharmaceutical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sichuan Kelun Pharmaceutical‘s full profile, request access.

Request a free trial

Sichuan Kelun Pharmaceutical Investments & Acquisitions (7)

Sichuan Kelun Pharmaceutical’s most recent deal was a Merger/Acquisition with Jiangsu Huashitong for . The deal was made on 15-Jul-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Jiangsu Huashitong 15-Jul-2025 Merger/Acquisition Pharmaceuticals
Kelun Biotech 29-Dec-2022 Later Stage VC Drug Discovery
Industrial Cloud Manufacturing 08-Apr-2022 Later Stage VC Business/Productivity Software
Cisen 28-Jul-2021 Secondary Transaction - Private Pharmaceuticals
Klus Pharma 28-Oct-2016 Merger/Acquisition Drug Discovery
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Sichuan Kelun Pharmaceutical ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

30.28 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Sichuan Kelun Pharmaceutical’s complete esg history, request access »

Sichuan Kelun Pharmaceutical Exits (1)

Sichuan Kelun Pharmaceutical’s most recent exit was on 29-Dec-2022 from Kelun Biotech. The exit was categorized as with 9 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Kelun Biotech 29-Dec-2022 Completed
  • 9 buyers
To view Sichuan Kelun Pharmaceutical’s complete exits history, request access »

Sichuan Kelun Pharmaceutical Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Kelun Biotech Chengdu, China 2016
Jiangsu Huashitong Taizhou, China 2016
Klus Pharma Princeton, NJ 2014

Sichuan Kelun Pharmaceutical FAQs

  • When was Sichuan Kelun Pharmaceutical founded?

    Sichuan Kelun Pharmaceutical was founded in 1996.

  • Where is Sichuan Kelun Pharmaceutical headquartered?

    Sichuan Kelun Pharmaceutical is headquartered in Chengdu, China.

  • What is the size of Sichuan Kelun Pharmaceutical?

    Sichuan Kelun Pharmaceutical has 20,127 total employees.

  • What industry is Sichuan Kelun Pharmaceutical in?

    Sichuan Kelun Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is Sichuan Kelun Pharmaceutical a private or public company?

    Sichuan Kelun Pharmaceutical is a Public company.

  • What is Sichuan Kelun Pharmaceutical’s stock symbol?

    The ticker symbol for Sichuan Kelun Pharmaceutical is 002422.

  • What is the current stock price of Sichuan Kelun Pharmaceutical?

    As of 18-Nov-2026 the stock price of Sichuan Kelun Pharmaceutical is $6.34.

  • What is the current market cap of Sichuan Kelun Pharmaceutical?

    The current market capitalization of Sichuan Kelun Pharmaceutical is $10.1B.

  • What is Sichuan Kelun Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Sichuan Kelun Pharmaceutical is $2.66B.

  • What is Sichuan Kelun Pharmaceutical’s annual earnings per share (EPS)?

    Sichuan Kelun Pharmaceutical’s EPS for 12 months was $0.18.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process